EMERGING PUBLIC BIOTECH

REPLIGEN CORP (RGEN)

Waltham, United States · North America
EMERGING PUBLIC BIOTECH
HEADQUARTERS
Waltham, United States
TICKER
RGEN
SEGMENT
Emerging Public Biotech
THERAPY AREAS
COMPANY OVERVIEW

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OP…

REPLIGEN CORP — FULL INTELLIGENCE

Live regulatory signals, patent cliffs, financials, tariff exposure and pipeline — all free on PharmaSignal.

OPEN PLATFORM →